STE
STERIS plc NYSE Listed Jun 1, 1992$213.75
Mkt Cap $21.0B
52w Low $204.81
13.8% of range
52w High $269.44
50d MA $224.19
200d MA $242.95
P/E (TTM)
34.4x
EV/EBITDA
17.9x
P/B
3.2x
Debt/Equity
0.3x
ROE
8.9%
P/FCF
28.7x
RSI (14)
—
ATR (14)
—
Beta
1.07
50d MA
$224.19
200d MA
$242.95
Avg Volume
872.4K
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
70 Sir John Rogerson's Quay · Dublin, L2 D02 R296 · IE
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | AMC | 2.53 | 2.53 | +0.0% | 264.27 | -9.1% | -7.7% | +3.4% | -2.7% | -0.3% | -0.5% | — |
| Nov 5, 2025 | AMC | 2.35 | 2.47 | +5.1% | 243.18 | +2.0% | +6.9% | +1.4% | +0.1% | +1.0% | +0.5% | — |
| Aug 6, 2025 | AMC | 2.26 | 2.34 | +3.5% | 221.21 | +2.7% | +6.8% | +2.8% | -0.5% | +0.9% | +1.4% | — |
| May 14, 2025 | AMC | 2.60 | 2.74 | +5.4% | 227.50 | +5.6% | +8.5% | +1.9% | +0.4% | -0.8% | -1.7% | — |
| Feb 5, 2025 | AMC | 2.33 | 2.32 | -0.4% | 220.83 | +0.3% | +2.1% | -1.0% | +0.5% | -0.4% | -1.9% | — |
| Nov 6, 2024 | AMC | 2.12 | 2.14 | +0.9% | 227.52 | -1.1% | -5.3% | +1.7% | +1.2% | +0.4% | -0.2% | — |
| Aug 6, 2024 | AMC | 1.98 | 2.03 | +2.5% | 239.18 | -0.5% | -2.4% | +2.6% | -1.5% | -0.9% | -0.1% | — |
| May 8, 2024 | AMC | 2.35 | 2.41 | +2.6% | 210.09 | +6.1% | +7.6% | +2.4% | +0.5% | +1.5% | -0.2% | — |
| Feb 7, 2024 | AMC | 2.17 | 2.22 | +2.3% | 225.87 | -3.5% | -2.5% | +1.8% | +0.3% | -0.2% | +1.4% | — |
| Nov 7, 2023 | AMC | 2.05 | 2.03 | -1.0% | 218.23 | -1.5% | -5.5% | -2.7% | -0.7% | +1.5% | +1.7% | — |
| Aug 1, 2023 | AMC | 1.86 | 2.00 | +7.5% | 224.01 | +12.3% | +1.7% | -1.0% | +0.2% | +0.1% | -0.4% | — |
| May 10, 2023 | AMC | 2.15 | 2.30 | +7.0% | 189.39 | +5.3% | +9.8% | +1.4% | -0.0% | -1.4% | -1.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8 | Morgan Stanley | Maintains | Overweight → Overweight | — | $236.24 | $238.60 | +1.0% | +2.8% | -0.5% | +0.9% | +1.4% | -0.4% |
| Jul 22 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $222.65 | $223.49 | +0.4% | +0.5% | +0.8% | +0.8% | +1.4% | -1.7% |
| Jul 15 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $225.79 | $228.94 | +1.4% | +1.4% | -0.5% | -1.3% | +0.4% | -1.3% |
| May 19 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $251.59 | $250.38 | -0.5% | +0.4% | -0.8% | -1.7% | -1.0% | -0.3% |
| May 16 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $246.88 | $246.64 | -0.1% | +1.9% | +0.4% | -0.8% | -1.7% | -1.0% |
| May 15 | Stephens & Co. | Maintains | Overweight → Overweight | — | $227.50 | $240.30 | +5.6% | +8.5% | +1.9% | +0.4% | -0.8% | -1.7% |
| May 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $226.43 | $230.00 | +1.6% | +2.9% | -0.8% | -1.6% | +8.5% | +1.9% |
| Apr 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $222.94 | $221.75 | -0.5% | -2.6% | +1.8% | +1.3% | -1.3% | -0.5% |
| Apr 7 | Needham | Maintains | Hold → Hold | — | $212.61 | $209.34 | -1.5% | +0.1% | -2.0% | +6.9% | -2.6% | +1.8% |
| Feb 6 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $220.83 | $221.46 | +0.3% | +2.1% | -1.0% | +0.5% | -0.4% | -1.9% |
| Feb 6 | Stephens & Co. | Maintains | Overweight → Overweight | — | $220.83 | $221.46 | +0.3% | +2.1% | -1.0% | +0.5% | -0.4% | -1.9% |
| Feb 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $220.65 | $218.38 | -1.0% | -1.0% | +0.5% | +0.7% | +2.1% | -1.0% |
| Nov 18 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $220.12 | $220.00 | -0.1% | -1.4% | -2.3% | +0.1% | +1.7% | -0.7% |
| Nov 7 | Stephens & Co. | Maintains | Overweight → Overweight | — | $227.52 | $225.05 | -1.1% | -5.3% | +1.7% | +1.2% | +0.4% | -0.2% |
| Oct 24 | Piper Sandler | Upgrade | Neutral → Overweight | — | $221.15 | $223.64 | +1.1% | +2.8% | -1.4% | -0.0% | -0.1% | +0.2% |
| Aug 7 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $239.18 | $238.04 | -0.5% | -2.4% | +2.6% | -1.5% | -0.9% | -0.1% |
| Aug 7 | Stephens & Co. | Maintains | Overweight → Overweight | — | $239.18 | $238.04 | -0.5% | -2.4% | +2.6% | -1.5% | -0.9% | -0.1% |
| Jul 26 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $227.56 | $228.31 | +0.3% | +2.3% | +1.5% | +0.4% | +0.6% | +0.9% |
| May 10 | Piper Sandler | Maintains | Neutral → Neutral | — | $225.99 | $225.50 | -0.2% | +2.4% | +0.5% | +1.5% | -0.2% | -2.0% |
| May 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $210.09 | $222.99 | +6.1% | +7.6% | +2.4% | +0.5% | +1.5% | -0.2% |
| Feb 9 | Stephens & Co. | Maintains | Overweight → Overweight | — | $220.26 | $220.77 | +0.2% | +1.8% | +0.3% | -0.2% | +1.4% | +2.4% |
| Feb 8 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $225.87 | $218.00 | -3.5% | -2.5% | +1.8% | +0.3% | -0.2% | +1.4% |
| Dec 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $203.51 | $201.90 | -0.8% | -2.1% | -0.4% | +0.4% | +1.4% | -0.7% |
| Nov 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $206.32 | $206.11 | -0.1% | -2.7% | -0.7% | +1.5% | +1.7% | -1.0% |
| Oct 27 | Piper Sandler | Maintains | Neutral → Neutral | — | $209.40 | $210.04 | +0.3% | -0.0% | -0.1% | +0.4% | +1.4% | -0.0% |
| Oct 26 | Piper Sandler | Maintains | Neutral → Neutral | — | $213.00 | $211.17 | -0.9% | -1.7% | -0.0% | -0.1% | +0.4% | +1.4% |
| Sep 25 | Stephens & Co. | Maintains | Overweight → Overweight | — | $223.94 | $223.86 | -0.0% | +0.8% | -1.1% | -2.4% | +2.0% | -1.2% |
| Sep 1 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $229.59 | $232.50 | +1.3% | +0.6% | -3.1% | +0.1% | +0.3% | -0.8% |
| Aug 3 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $227.80 | $227.07 | -0.3% | -1.0% | +0.2% | +0.1% | -0.4% | +0.8% |
| Aug 3 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $227.80 | $227.07 | -0.3% | -1.0% | +0.2% | +0.1% | -0.4% | +0.8% |
| Aug 2 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $224.01 | $251.66 | +12.3% | +1.7% | -1.0% | +0.2% | +0.1% | -0.4% |
| Jul 25 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $232.17 | $231.32 | -0.4% | +0.4% | -0.5% | -0.9% | +0.1% | -2.0% |
| Jul 17 | Stephens & Co. | Maintains | Overweight → Overweight | — | $229.08 | $229.02 | -0.0% | -0.3% | -0.6% | +0.2% | +1.2% | +0.8% |
| May 12 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $208.00 | $208.00 | +0.0% | +1.4% | -0.0% | -1.4% | -1.0% | +0.5% |
| May 12 | Piper Sandler | Maintains | Neutral → Neutral | — | $208.00 | $208.00 | +0.0% | +1.4% | -0.0% | -1.4% | -1.0% | +0.5% |
| May 11 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $189.39 | $199.49 | +5.3% | +9.8% | +1.4% | -0.0% | -1.4% | -1.0% |
| Apr 14 | Piper Sandler | Downgrade | Overweight → Neutral | — | $195.12 | $190.52 | -2.4% | -4.4% | +0.9% | -2.3% | +1.6% | -0.7% |
| Feb 15 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $194.84 | $193.43 | -0.7% | +1.7% | -3.3% | -1.1% | -2.5% | +0.1% |
| Feb 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $192.34 | $191.72 | -0.3% | +0.3% | +1.8% | -0.8% | +1.7% | -3.3% |
| Feb 9 | Stephens & Co. | Maintains | Overweight → Overweight | — | $215.85 | $201.45 | -6.7% | -10.9% | +0.3% | +1.8% | -0.8% | +1.7% |
| Nov 11 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $169.27 | $168.88 | -0.2% | +1.9% | -2.8% | -0.0% | -0.8% | -0.2% |
| Sep 23 | Needham | Downgrade | Buy → Hold | — | $176.76 | $172.43 | -2.4% | -5.4% | -1.9% | -2.1% | +1.3% | +2.6% |
| Aug 4 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $203.00 | $201.84 | -0.6% | +2.5% | +1.9% | +0.7% | -2.1% | +0.6% |
| Aug 4 | Needham | Maintains | Buy → Buy | — | $203.00 | $201.84 | -0.6% | +2.5% | +1.9% | +0.7% | -2.1% | +0.6% |
| May 13 | Needham | Maintains | Buy → Buy | — | $218.39 | $220.24 | +0.8% | -1.0% | +0.8% | +1.7% | -1.1% | +2.0% |
| Feb 14 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $229.79 | $230.50 | +0.3% | -1.4% | +2.6% | +0.3% | -2.7% | -0.3% |
| Feb 10 | Needham | Maintains | Buy → Buy | — | $237.35 | $234.43 | -1.2% | -1.7% | -1.5% | -1.4% | +2.6% | +0.3% |
| Nov 4 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $222.72 | $223.97 | +0.6% | -0.2% | +1.1% | +2.4% | -0.4% | +1.3% |
| Nov 4 | Stephens & Co. | Maintains | Overweight → Overweight | — | $222.72 | $223.97 | +0.6% | -0.2% | +1.1% | +2.4% | -0.4% | +1.3% |
| Aug 11 | Baird | Maintains | Outperform → Outperform | — | $217.62 | $217.41 | -0.1% | -0.0% | +0.3% | +0.3% | +1.4% | +1.7% |
No insider trades available.
8-K
Unknown — 8-K Filing
I cannot provide meaningful analysis of this 8-K filing for STE because the provided summary contains only standard boilerplate signature language with no substantive disclosures about events, transactions, or material changes affecting the company.
Apr 6
8-K
STERIS plc -- 8-K Filing
STERIS achieved 9% revenue growth in Q3 fiscal 2026, reaching $1.5 billion, driven by 8% constant currency organic expansion, signaling strong operational momentum across its healthcare solutions business.
Feb 4
Data updated apr 27, 2026 3:06am
· Source: massive.com